Login / Signup

Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study.

Anat SternCarolyn D AlonsoCarolina García-VidalCelia CardozoMonica A SlavinMichelle K YongSu Ann HoSeema Mehta SteinkeRobin K AveryPhilipp KoehlerChristof ScheidOliver Andreas CornelyJohan MaertensYasmine Abi AadDavid J EpsteinGenovefa A PapanicolaouDionysios Neofytos
Published in: The Journal of antimicrobial chemotherapy (2021)
One in four HCT recipients treated with IV cidofovir developed largely reversible nephrotoxicity. Careful selection of patients and close follow-up of renal function may minimize toxicity.
Keyphrases
  • newly diagnosed
  • ejection fraction
  • clinical trial
  • prognostic factors
  • oxidative stress
  • cell therapy
  • cross sectional
  • drug induced